Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in PRQR — ProQR Therapeutics N.V.

CIK 1000275 TORONTO, A6
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,147
+$5,649 QoQ
Shares Held
3,305
+973.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 69 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. PRQR ranks #314 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in PRQR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,147 3,305
2026-03-31 $498 308
2025-12-31 $20,812 10,303
2025-09-30 $196,400 92,207
2025-06-30 $229,296 112,400
2025-03-31 $266 200
2024-12-31 $530 200
2024-09-30 $364 200
2024-06-30 $1,751 1,055
2024-03-31 $458 200
2023-12-31 $396 200
2023-09-30 $260 200
2023-06-30 $324 200
2023-03-31 $426 200
2022-12-31 $740 200
2022-09-30 $148 200
2022-06-30 $155 200
2022-03-31 $50,927 56,273
2021-12-31 $450,746 56,273
2021-09-30 $487,745 58,273
2021-06-30 $372,540 55,273
2021-03-31 $360,958 54,608
2020-12-31 $220,953 52,608
2020-09-30 $254,626 53,158
2020-06-30 $393,120 64,658
2020-03-31 $84,556 15,402